Mayo Clinic, Rochester, Minnesota, USA.
Baylor Scott & White Health, Plano, Texas, USA.
JACC Cardiovasc Interv. 2023 Sep 25;16(18):2195-2210. doi: 10.1016/j.jcin.2023.06.044.
Mitral annular calcium (MAC) with severe mitral valvular dysfunction presents a complex problem, as valve replacement, either surgical or transcatheter, is challenging because of anatomy, technical considerations, concomitant comorbidities, and advanced age. The authors review the clinical and anatomical features of MAC that are favorable (green light), challenging (yellow light), or prohibitive (red light) for surgical or transcatheter mitral valve interventions. Under the auspices of the Heart Valve Collaboratory, an expert working group of cardiac surgeons, interventional cardiologists, and interventional imaging cardiologists was formed to develop recommendations regarding treatment options for patients with MAC as well as a proposed grading and staging system using both anatomical and clinical features.
二尖瓣环钙(MAC)伴严重二尖瓣瓣膜功能障碍提出了一个复杂的问题,因为由于解剖结构、技术考虑因素、合并并存疾病和高龄,瓣膜置换术,无论是外科手术还是经导管,都具有挑战性。作者回顾了 MAC 的临床和解剖特征,这些特征对手术或经导管二尖瓣瓣膜干预是有利的(绿灯)、有挑战性的(黄灯)或禁忌的(红灯)。在心瓣膜协作组织的主持下,成立了一个由心脏外科医生、介入心脏病学家和介入影像学心脏病学家组成的专家工作组,旨在为 MAC 患者的治疗选择制定建议,并提出使用解剖和临床特征的分级和分期系统。